Ribomic Inc
TSE:4591
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HIT Welding Industry Co Ltd
SZSE:301137
|
CN |
|
Kobayashi Yoko Co Ltd
TSE:8742
|
JP |
|
T
|
Transtema Group AB
STO:TRANS
|
SE |
|
Corsair Gaming Inc
NASDAQ:CRSR
|
US |
|
Beiersdorf AG
XETRA:BEI
|
DE |
Ribomic Inc
Total Receivables
Ribomic Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ribomic Inc
TSE:4591
|
Total Receivables
¥44.7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
|
|
SanBio Co Ltd
TSE:4592
|
Total Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Total Receivables
¥8.1B
|
CAGR 3-Years
37%
|
CAGR 5-Years
43%
|
CAGR 10-Years
61%
|
|
|
PeptiDream Inc
TSE:4587
|
Total Receivables
¥5.9B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
27%
|
|
|
Takara Bio Inc
TSE:4974
|
Total Receivables
¥8.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Total Receivables
¥420.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
20%
|
CAGR 10-Years
33%
|
|
Ribomic Inc
Glance View
RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 25 full-time employees. The company went IPO on 2014-09-25. Its drug discovery business is divided into self discovery and co-discovery divisions. Self Drug Discovery division develops aptamer and licenses and out the results to pharmaceutical companies. The Co-Discovery division earns the research expenses paid by the alliance partner for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.
See Also
What is Ribomic Inc's Total Receivables?
Total Receivables
44.7m
JPY
Based on the financial report for Dec 31, 2025, Ribomic Inc's Total Receivables amounts to 44.7m JPY.
What is Ribomic Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
25%
Over the last year, the Total Receivables growth was 7%. The average annual Total Receivables growth rates for Ribomic Inc have been -7% over the past three years , 10% over the past five years , and 25% over the past ten years .
